Intestinal permeability biomarkers in patients with schizophrenia: Additional support for the impact of lifestyle habits
Year: 2024
Type: article
Study design: Observational Study
Abstract: Background Emerging evidence suggests a potential association between “leaky gut syndrome” and low-grade systemic inflammation in individuals with psychiatric disorders, such as schizophrenia. Gut dysbiosis could increase intestinal permeability, allowing the passage of toxins and bacteria into the systemic circulation, subsequently triggering immune-reactive responses. This study delves into understanding the relationship between plasma markers of intestinal permeability and symptom severity in schizophrenia. Furthermore, the influence of lifestyle habits on these intestinal permeability markers was determined. Methods Biomarkers of intestinal permeability, namely lipopolysaccharide-binding protein (LBP), lipopolysaccharides (LPS), and intestinal fatty acid binding protein (I-FABP), were analyzed in 242 adult schizophrenia patients enrolled in an observational, cross-sectional, multicenter study from four centers in Spain (PI17/00246). Sociodemographic and clinical data were collected, including psychoactive drug use, lifestyle habits, the Positive and Negative Syndrome Scale to evaluate schizophrenia symptom severity, and the Screen for Cognitive Impairment in Psychiatry to assess cognitive performance. Results Results revealed elevated levels of LBP and LPS in a significant proportion of patients with schizophrenia (62% and 25.6%, respectively). However, no statistically significant correlation was observed between these biomarkers and the overall clinical severity of psychotic symptoms or cognitive performance, once confounding variables were controlled for. Interestingly, adherence to a Mediterranean diet was negatively correlated with I-FABP levels (beta = −0.186, t = −2.325, p = 0.021), suggesting a potential positive influence on intestinal barrier function. Conclusions These findings underscore the importance of addressing dietary habits and promoting a healthy lifestyle in individuals with schizophrenia, with potential implications for both physical and psychopathological aspects of the disorder.
Source: European Psychiatry
Institutions: Universidad de Oviedo, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Investigación Sanitaria del Principado de Asturias, Servicio de Salud del Principado de Asturias, Parc Sanitari Sant Joan de Déu, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Universitat Autònoma de Barcelona, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, University Hospital Mútua de Terrassa, Mútua Terrassa, Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre, Hospital Universitario 12 De Octubre
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,150
Funders: Gobierno del Principado de Asturias, Ministerio de Ciencia, Innovación y Universidades, Centres de Recerca de Catalunya, Universitat de Barcelona, Centro de Investigación Biomédica en Red de Salud Mental, Agència de Gestió d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III, European Regional Development Fund, European Social Fund
Awards: G1808458621, G2901997439, G3622567221, G4806979115, Eje microbioma-intestino-cerebro y marcadores inflamatorios relacionados en pacientes con esquizofrenia, Estudio de aplicabilidad clínica de un modelo predictivo de recaídas en primeros episodios de esquizofrenia, G6551428496, G736885710, G76789454, La permeabilidad intestinal como causa de inflamación crónica de bajo grado en pacientes con esquizofrenia: relación con la dieta, el síndrome metabólico y la gravedad de la enfermedad
OpenAlex ID: W4405454792
